3BBLACKBIO — 3B Blackbio DX Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeSmall CapNeutral

Annual income statement for 3B Blackbio DX, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	R2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	806	618	741	965	1,419
Cost of Revenue
Gross Profit	490	439	523	708	1,061
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	442	336	422	474	903
Operating Profit	364	283	319	490	516
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	432	353	443	640	770
Provision for Income Taxes
Net Income After Taxes	322	259	321	477	599
Minority Interest
Net Income Before Extraordinary Items
Net Income	322	259	321	477	586
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	322	259	321	477	586
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	43	30.3	37.5	55.6	69.9
Dividends per Share
Special Dividends per Share